Replies to post #269784 on NorthWest Biotherapeutics Inc (NWBO)

[alphapuppy]

Umb

I agree with your analysis.

In a way I am glad that this Communication issue has forced to DI to further state that He believes I had misinterpreted his comments. This is a good thing. Because it has forced him to not be on the fence about this. And this therefore is a confirmation of sorts.

Basically this just reaffirms that The company will present something interesting or very interesting at the ASM.

I don’t know if that’s going to be a timeline of events or an actual unbinding or an analysis of the trial or a buyout or what.

I suspect it will be interesting but not earth shattering.

[sukus]

Potentially exciting...
Going to let loose finally in first half of this year? No half baked data and no extrapolation to reach conclusion of this final result? Gold standard data? No more shackled by self imposed restrained? Stats significant? European news? FDA news?

Yup. First thing first, release TLD and everything else would fall into place nicely.

April 18
“Interesting” - ASM news
“Very interesting” - LG
“Very exciting” - LG

Mid May
“Significant event” - DI

TLD?

[longfellow95]

Umibe, I don't think it was actually a PR.

It was within an email sent to shareholders.

I think it was subsequently issued as a 'news release', but it's not listed unders PR's on the NWBO website.

I don't know whether you will think this is at all significant, or whether it makes any difference to the points in your post.

[HappyLibrarian]

With any other company, what you are saying is indisputable but NWBO has a history of making self-destructive decisions though this one, if they do it would be on a whole new level, almost as bad as how they handled Neil Woodford but on par with HE or the Swiss Approval.

Still there’s a good chance you’re right and my posts reflect the cautious aspect of my cautious optimism.